BIO Medical Applications Of Alabama Inc is a medicare approved dialysis facility center in Decatur, Alabama and it has 20 dialysis stations. It is located in Morgan county at 2834 Spring Avenue Sw, Decatur, AL, 35603.
You can reach out to the office of BIO Medical Applications Of Alabama Inc at (256) 885-1740. This dialysis clinic is managed and/or owned by Fresenius Medical Care. BIO Medical Applications Of Alabama Inc has the following ownership type - Profit. It was first certified by medicare in February, 2017. The medicare id for this facility is 012692 and it accepts patients under medicare ESRD program.
Dialysis Center Profile
| Name | BIO Medical Applications Of Alabama Inc |
|---|
| Location | 2834 Spring Avenue Sw, Decatur, Alabama |
|---|
| No. of Dialysis Stations | 20 |
|---|
| Medicare ID | 012692 |
|---|
| Managed By | Fresenius Medical Care |
|---|
| Ownership Type | Profit |
|---|
| Late Shifts | No |
|---|
NPI Associated with this Dialysis Facility:
Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with BIO Medical Applications Of Alabama Inc
from NPPES records by matching pattern on the basis of name, address, phone number etc.
Please use this information accordingly.
| NPI Number | 1760839922 |
| Organization Name | Fresenius Medical Care Decatur |
| Doing Business As | Bio-medical Applications Of Alabama, Inc. |
| Address | 2834 Spring Ave Sw Decatur, Alabama, 35603 |
| Phone Number | (256) 306-4735 |
Patient Distribution
Anemia Management
| Dialysis patients with Hemoglobin data | 11 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 27 |
Dialysis Adequacy
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
- Hemodialysis
| Adult patients getting regular hemodialysis at the center | 28 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 128 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center | |
Mineral and Bone Disorder
An important goal of dialysis is to maintain normal levels of various minerals
in the body, such as calcium. This shows the percentage of patients
treated at BIO Medical Applications Of Alabama Inc with elevated calcium levels.
| Patients with hypercalcemia | 28 |
| Hypercalcemia patient months | 128 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 30 |
| Patients with Serumphosphor less than 3.5 mg/dL | 1 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 19 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 26 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 37 |
| Patients with Serumphosphor greater than 7 mg/dL | 16 |
Vascular Access
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it
allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access.
Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 30 |
| Patient months included in arterial venous fistula and catheter summaries | 137 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 77 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 9 |